These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 220858)
81. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Sugden B Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034 [TBL] [Abstract][Full Text] [Related]
89. Epstein-Barr virus and infectious mononucleosis. Henle W; Henle G N Engl J Med; 1973 Feb; 288(5):263-4. PubMed ID: 4345065 [No Abstract] [Full Text] [Related]
90. Epstein-Barr virus--discovery, properties and relationship to nasopharyngeal carcinoma. Epstein MA IARC Sci Publ (1971); 1978; (20):333-45. PubMed ID: 215517 [No Abstract] [Full Text] [Related]
91. Activation of Epstein-Barr virus in hybrid cells. Tsang KY; Hann WD J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898 [TBL] [Abstract][Full Text] [Related]
92. Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection. Lai PK; Alpers MP Comp Immunol Microbiol Infect Dis; 1979; 2(4):565-85. PubMed ID: 232867 [No Abstract] [Full Text] [Related]
93. [Significance of the Epstein-Barr virus in infectious mononucleosis and malignant tumors]. Goetz O; Peller P Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):324-7. PubMed ID: 4328620 [No Abstract] [Full Text] [Related]
94. Enzyme-linked immunosorbent assay of antibodies to Epstein-Barr virus nuclear and early antigens in patients with infectious mononucleosis and nasopharyngeal carcinoma. Halprin J; Scott AL; Jacobson L; Levine PH; Ho JH; Niederman JC; Hayward SD; Milman G Ann Intern Med; 1986 Mar; 104(3):331-7. PubMed ID: 3004279 [TBL] [Abstract][Full Text] [Related]
95. Epstein-Barr virus in oropharyngeal and nasopharyngeal secretions of patients with nasopharyngeal carcinoma and control subjects. Tsao SY; He Y; Cheng PM; Ho S; Leung SF; Chang RS Intervirology; 1991; 32(4):209-15. PubMed ID: 1650762 [TBL] [Abstract][Full Text] [Related]
96. New clinical manifestations of Epstein-Barr virus infection. Lancet; 1982 Dec; 2(8310):1253-5. PubMed ID: 6128552 [No Abstract] [Full Text] [Related]
97. The immunological approach to study of possibly virus-induced human malignancies using the Epstein-Barr virus as example. Henle W; Henle G Prog Exp Tumor Res; 1978; 21():19-48. PubMed ID: 205906 [No Abstract] [Full Text] [Related]
98. A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis. Smith RS; Rhodes G; Vaughan JH; Horwitz CA; Geltosky JE; Whalley AS J Infect Dis; 1986 Nov; 154(5):885-9. PubMed ID: 3021871 [No Abstract] [Full Text] [Related]
99. Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases. Henle W; Henle G Ann N Y Acad Sci; 1980; 354():326-31. PubMed ID: 6261650 [No Abstract] [Full Text] [Related]
100. Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease. Klein G Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():783-90. PubMed ID: 169032 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]